Market Size of Mental Disorder Treatment Market Expected to Reach US$75.7 Billion at a CAGR of 6.6% through 2027 | Allergan plc, Eli Lilly and Company, VistaGen Therapeutics, Sanofi SA

Coherent Market Insights published a trade research report on Mental Disorder Treatment Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecasts 2022-2028. Mental Disorder Treatment Market with 150+ market data tables, pie chart, graphs and figures spread across pages and easy to understand detailed analysis. The information is collected on the basis of modern floats and requests identified with administrations and posts.

Mental disorder treatment market finds inner peace in business growth advised by increasing government support amid rising suicide cases

Overview

People with severe mental disorders have a higher risk of suicide than those without a psychiatric diagnosis. Although this disease is not a sign of violence, it is associated with a greater probability of death. Consequently, many people with mental disorders may be at increased risk of suicide or other serious harm. The treatment options available for people with mental disorders vary widely. In some cases, medications and other treatments may be needed to improve the person’s condition. In some cases, a person with a mental disorder may be prescribed antipsychotic medication or therapy. The duration of these treatments will depend on the specific cause of the disorder. In some cases, people with severe mental illness may require intensive care or be admitted to a psychiatric hospital for a period of time. However, this is only necessary when the person with a mental disorder exhibits risky behaviors. During this time, the patient will receive counseling and participate in activities with other patients.

Request Free Toc Sample Report – https://www.coherentmarketinsights.com/insight/request-sample/4326

Competitive landscape

Major companies contributing to the global mental disorder treatment market include Cipla Ltd., Glenmark Pharmaceuticals Limited, Mylan NV, Sanofi SA, VistaGen Therapeutics, Eli Lilly and Company, Allergan plc, Sumitomo Dainippon Pharma Co., Ltd., Bristol Myers Squibb, Janssen Pharmaceutica, Novartis International AG, Amneal Pharmaceuticals LLC, Lupin Limited and Sun Pharmaceutical Industries Ltd.

Drivers

The high demand for effective treatments for anxiety management amid rising cases of psychological disorders is expected to increase the growth of the mental disorder treatment market during the forecast period.

Additionally, increase in government and non-governmental organizations (NGO) initiatives to create mental health awareness amid rising suicide cases is expected to further dampen the growth of the mental disorder treatment market over the forecast period. .

Summary of the consequences of COVID-19

The onset of the COVID-19 crisis positively influenced the global mental disorder treatment market. Restrictions on movement and outdoor activities have forced a large part of the population to stay indoors, which, in turn, has led to serious mental disorders. Rising unemployment rates and social distancing measures have created a positive growth outlook for the market.

𝐁𝐮𝐲 𝐍𝐨𝐰 𝐚𝐧𝐝 𝐆𝐞𝐭 𝐅𝐥𝐚𝐭 𝐔𝐒𝐃 𝟐𝟎𝟎𝟎

To buy this research report directly – https://www.coherentmarketinsights.com/promo/buynow/4326

Key points to remember

  • The mental disorder treatment market is expected to grow at a CAGR of XX% during the forecast period owing to the increase in mental disorder cases among patients suffering from non-communicable diseases and the advent of new methods of diagnostic. For example, in February 2022, researchers at the University of Oxford reported that people with chronic respiratory conditions were 50% more likely to develop mental illness.
  • In the group of regions, North America is expected to dominate the global mental disorder treatment market owing to the increase in occurrence of various phobias, rise in suicide cases and rising popularity of mHealth applications .
  • In the same vein, the Asia-Pacific region is expected to be a profit hub for the global mental disorder treatment market on the heels of rising prevalence of sleep disorders, increase in government measures and number growing number of virtual consultation services.

To get the Covid-19 impact PDF brochure of this report @ https://www.coherentmarketinsights.com/insight/request-pdf/4326

Contents

  1. Research objectives and hypotheses
    • Research objectives
    • Hypotheses
    • Abbreviations
  2. Market scope
    • Description of the report
      • Market definition and scope
    • Summary
      • Market Overview, By Disorder Type
      • Market Overview, By Drug
      • Market overview, by distribution channel
      • Market Overview, By Region
    • Consistent Opportunity Map (COM)
  3. Market dynamics, regulation and trend analysis
    • Drivers
    • Constraints
    • Opportunities
    • Impact analysis
    • Key developments
    • New product launches/approvals
    • M&A scenario
    • Regulatory scenario
    • Pipeline analysis
    • Epidemiology
    • PEST analysis
    • Repayment
  4. Global Treatment of mental disorders Market, impact of the COVID-19 pandemic
    • Impact of COVID 19 on mental health
    • Impact of COVID 19 on supply and demand
  5. Global Treatment of mental disorders Market, by type of disorder, 2016-2027 (USD Billion)
    • introduction
      • Market share analysis, 2020 and 2027 (%)
      • Annual Growth Analysis, 2017-2027
      • Industry trends
        • Depression
          • introduction
          • Market Size & Forecast, and Annual Growth, 2016-2027, (USD Billion)
        • Bipolar disorder
          • introduction
          • Market Size & Forecast, and Annual Growth, 2016-2027, (USD Billion)
        • Schizophrenia
          • introduction
          • Market Size & Forecast, and Annual Growth, 2016-2027, (USD Billion)
        • Dementia
          • introduction
          • Market Size & Forecast, and Annual Growth, 2016-2027, (USD Billion)
        • post-traumatic stress disorder
          • introduction
          • Market Size & Forecast, and Annual Growth, 2016-2027, (USD Billion)
        • Others
          • introduction
          • Market Size & Forecast, and Annual Growth, 2016-2027, (USD Billion)
  6. Global Treatment of mental disorders Market, by drug, 2016-2027 (USD Billion)
    • introduction
      • Market share analysis, 2020 and 2027 (%)
      • Annual Growth Analysis, 2017-2027
      • Industry trends
        • Antidepressants
          • introduction
          • Market Size & Forecast, and Annual Growth, 2016-2027, (USD Billion)
        • Anti stress
          • introduction
          • Market Size & Forecast, and Annual Growth, 2016-2027, (USD Billion)
        • Mood-stabilizing drugs
          • introduction
          • Market Size & Forecast, and Annual Growth, 2016-2027, (USD Billion)
        • Antipsychotic drugs
          • introduction
          • Market Size & Forecast, and Annual Growth, 2016-2027, (USD Billion)
  7. Global Mental Disorder Treatment Market, By Distribution channel2016–2027 (USD Billion)
    • introduction
      • Market share analysis, 2020 and 2027 (%)
      • Annual Growth Analysis, 2017-2027
      • Industry trends
        • Hospital pharmacies
          • introduction
          • Market Size & Forecast, and Annual Growth, 2016-2027, (USD Billion)
        • Retail pharmacies
          • introduction
          • Market Size & Forecast, and Annual Growth, 2016-2027, (USD Billion)
        • Online pharmacies
          • introduction
          • Market Size & Forecast, and Annual Growth, 2016-2027, (USD Billion)

See press release: https://www.coherentmarketinsights.com/press-release/mental-disorder-treatment-market-3586

About Us:

Coherent Market Insights is a global market intelligence and advisory organization that provides syndicated research reports, custom research reports and advisory services. We’re known for our actionable insights and genuine reports in a variety of fields, including aerospace and defense, agriculture, food and beverage, automotive, chemicals and materials, and virtually any field and an exhaustive list of subdomains under the sun. We create value for our clients through our highly reliable and accurate reports. We are also committed to playing a leading role in providing insight in various post-COVID-19 sectors and to continuing to deliver measurable and sustainable results to our clients.

Contact us:

Consistent market information
1001 4th Ave, #3200 Seattle, WA 98154, USA
Email: [email protected]
United States of America: +1-206-701-6702
UK: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

Comments are closed.